This inventor holds 4 USPTO granted patents. Top assignees: Takeda Pharmaceutical Company Limited, Day One Biopharmaceuticals, Inc., Dot Therapeutics-1, Inc.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014-2024
Title: Jun-ichi Kawakami: Innovator in Optically Active Compounds
Introduction
Jun-ichi Kawakami is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the production of optically active compounds. With a total of 4 patents to his name, Kawakami's work is recognized for its industrial applications and innovative methodologies.
Latest Patents
Kawakami's latest patents focus on methods for producing optically active pyrimidinamide derivatives on an industrial scale. The first patent outlines a process where compound (I) or a salt thereof undergoes an asymmetric reduction reaction. The resulting compound (II) or a salt is then subjected to a deprotection reaction. Finally, the obtained compound (III) or a salt is reacted with compound (VI) or a salt to yield compound (V) or a salt. This method aims to enhance the efficiency and scalability of producing these valuable compounds.
Career Highlights
Throughout his career, Jun-ichi Kawakami has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Takeda Pharmaceutical Company Limited and Dot Therapeutics-1, Inc. His experience in these organizations has contributed to his expertise in developing innovative chemical processes.
Collaborations
Kawakami has collaborated with esteemed colleagues, including Masatoshi Yamada and Sayuri Hirano. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Jun-ichi Kawakami's contributions to the field of chemistry, particularly in the production of optically active compounds, highlight his innovative spirit and dedication to advancing industrial methodologies. His work continues to influence the pharmaceutical industry and inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile